218 related articles for article (PubMed ID: 20652725)
61. Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas.
Hussein MR; El-Ghorori RM; El-Rahman YG
Int J Exp Pathol; 2006 Aug; 87(4):297-306. PubMed ID: 16875495
[TBL] [Abstract][Full Text] [Related]
62. Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2.
Vollmer RT; Humphrey PA; Swanson PE; Wick MR; Hudson ML
Cancer; 1998 Feb; 82(4):715-23. PubMed ID: 9477105
[TBL] [Abstract][Full Text] [Related]
63. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
64. Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival.
Arshad H; Ahmad Z; Hasan SH
Asian Pac J Cancer Prev; 2010; 11(6):1637-40. PubMed ID: 21338209
[TBL] [Abstract][Full Text] [Related]
65. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells.
Blümcke I; Becker AJ; Normann S; Hans V; Riederer BM; Krajewski S; Wiestler OD; Reifenberger G
J Neuropathol Exp Neurol; 2001 Oct; 60(10):984-93. PubMed ID: 11589429
[TBL] [Abstract][Full Text] [Related]
66. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
67. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
68. Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity.
Ye F; Gao Q; Xu T; Zeng L; Ou Y; Mao F; Wang H; He Y; Wang B; Yang Z; Guo D; Lei T
J Neurooncol; 2009 Sep; 94(2):183-94. PubMed ID: 19300910
[TBL] [Abstract][Full Text] [Related]
69. Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers.
Figarella-Branger D; Maues de Paula A; Colin C; Bouvier C
Rev Neurol (Paris); 2011 Oct; 167(10):683-90. PubMed ID: 21889777
[TBL] [Abstract][Full Text] [Related]
70. Function of aberrant EGFR in malignant gliomas.
Sugawa N; Yamamoto K; Ueda S; Morita N; Kita M; Nishino H; Fushiki S; Okabe T
Brain Tumor Pathol; 1998; 15(1):53-7. PubMed ID: 9879464
[TBL] [Abstract][Full Text] [Related]
71. Experimental validation of 5 in-silico predicted glioma biomarkers.
Towner RA; Jensen RL; Vaillant B; Colman H; Saunders D; Giles CB; Wren JD
Neuro Oncol; 2013 Dec; 15(12):1625-34. PubMed ID: 24158112
[TBL] [Abstract][Full Text] [Related]
72. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
[TBL] [Abstract][Full Text] [Related]
73. Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma.
Lu F; Chen Y; Zhao C; Wang H; He D; Xu L; Wang J; He X; Deng Y; Lu EE; Liu X; Verma R; Bu H; Drissi R; Fouladi M; Stemmer-Rachamimov AO; Burns D; Xin M; Rubin JB; Bahassi EM; Canoll P; Holland EC; Lu QR
Cancer Cell; 2016 May; 29(5):669-683. PubMed ID: 27165742
[TBL] [Abstract][Full Text] [Related]
74. Podoplanin: a marker for reactive gliosis in gliomas and brain injury.
Kolar K; Freitas-Andrade M; Bechberger JF; Krishnan H; Goldberg GS; Naus CC; Sin WC
J Neuropathol Exp Neurol; 2015 Jan; 74(1):64-74. PubMed ID: 25470350
[TBL] [Abstract][Full Text] [Related]
75. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
76. Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain.
Guillaudeau A; Durand K; Rabinovitch-Chable H; Pommepuy I; Mesturoux L; Robert S; Chaunavel A; Moreau JJ; Labrousse F
Int J Oncol; 2012 Apr; 40(4):1142-52. PubMed ID: 22159595
[TBL] [Abstract][Full Text] [Related]
77. Determination of EGFR status in gliomas: usefulness of immunohistochemistry and fluorescent in situ hybridization.
Guillaudeau A; Durand K; Pommepuy I; Robert S; Chaunavel A; Lacorre S; DeArmas R; Bourtoumieux S; El Demery M; Moreau JJ; Labrousse F
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):220-6. PubMed ID: 19391220
[TBL] [Abstract][Full Text] [Related]
78. Modeling glioma growth and invasion in Drosophila melanogaster.
Witte HT; Jeibmann A; Klämbt C; Paulus W
Neoplasia; 2009 Sep; 11(9):882-8. PubMed ID: 19724682
[TBL] [Abstract][Full Text] [Related]
79. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
80. Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities.
Pallud J; Varlet P; Devaux B; Geha S; Badoual M; Deroulers C; Page P; Dezamis E; Daumas-Duport C; Roux FX
Neurology; 2010 May; 74(21):1724-31. PubMed ID: 20498440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
